What is metformin, the old diabetes drug some people are taking for weight loss?
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
Hims & Hers: Capitalizing On The GLP-1 Rush Before The Window Closes (Rating Upgrade)
Hims & Hers projects $725M in GLP-1 weight loss revenue for 2025, a 3.2x increase from 2024. Read why I upgrade HIMS stock ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...
Wall Street Breakfast Podcast: Bitcoin Slips Below $90K As Crypto Stumbles
Bitcoin breaks below $90,000 as crypto selloff deepens. Apple, Indonesia reportedly agree on terms to end iPhone 16 ban. Drug ...
Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
Smokescreen: some vape firms pivot after FDA crackdown
Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...
The Alpena News5h
FDA moves to rehire staffers fired days earlier
Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news over the weekend: The government wants them back. Beginning Friday night, FDA ...
FDA Asks 300 Fired Scientists to Return
Some FDA scientists said they were not sure if they wanted to return. The U.S. Food and Drug Administration is asking some of ...
montanarightnow13h
New FDA healthy food label rules pushed back in light of President Donald Trump's order
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will ...
Becker's Hospital Review13h
Pfizer names former FDA official as chief medical officer
Pfizer has appointed former Patrizia Cavazzoni, MD, former director of the FDA's Center for Drug Evaluation and Research, as its new chief medical officer, Bloomberg reported Feb. 24. Dr. Cavazzoni, ...